Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001301120-26-000008

Chief Scientific Officer sold 2,500 shares at $2.95 ($7,375)

  • Chief Scientific Officer acquired 2,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moreadith Randall · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-22 Exercise or conversion : show line 1 in the form 10b5-1 +2,500 $0.06 $150 2,500 D
2026-01-22 Sale : show line 2 in the form 10b5-1 −2,500 $2.95 $7,375 0 D
Open-market sales · 2,500 sh · avg $2.95 · $7,375

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-22 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −2,500 326,186 D
Loading xslF345X05/wk-form4_1769189706.xml…